|
⚲
|
| Keyboard |
| Deerfield Capital LP
✚
|
|
|---|---|
| CIK # | 0001010823 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001010823] | |
| 4 | [0001010823] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Zafgen Inc LRMR
Common Stock
|
2026-02-27 | Buy | 1,084,010 | $5.00 | 5,420,050 |
|
Zafgen Inc LRMR
Common Stock
|
2026-02-27 | Buy | 831,978 | $5.00 | 4,159,890 |
|
Zafgen Inc LRMR
Common Stock
|
2026-02-27 | Buy | 1,084,012 | $5.00 | 5,420,060 |
|
Zafgen Inc LRMR
Common Stock
|
2026-02-27 | Buy | 2,000,000 | $5.00 | 10,000,000 |
|
Nuvalent Inc NUVL
Class A Common Stock
|
2025-11-24 | Sell | 371,287 | $95.45 | 35,439,344 |
|
Nuvalent Inc NUVL
Class A Common Stock
|
2025-11-24 | Sell | 371,287 | $95.45 | 35,439,344 |
|
Zafgen Inc LRMR
Common Stock
|
2025-07-31 | Buy | 3,387,529 | $3.20 | 10,840,093 |
|
Zafgen Inc LRMR
Common Stock
|
2025-07-31 | Buy | 2,599,932 | $3.20 | 8,319,782 |
|
Zafgen Inc LRMR
Common Stock
|
2025-07-31 | Buy | 3,387,539 | $3.20 | 10,840,125 |
|
Nuvalent Inc NUVL
Class A Common Stock
|
2024-10-22 | Sell | 1,000,000 | $97.75 | 97,750,000 |
|
Nuvalent Inc NUVL
Class A Common Stock
|
2024-10-22 | Sell | 1,000,000 | $97.75 | 97,750,000 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-17 | Buy | 35,000 | $18.00 | 630,000 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-17 | Conversion | 862,587 | ||
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-17 | Buy | 35,000 | $18.00 | 630,000 |
|
Bicara Therapeutics Inc BCAX
Common Stock
|
2024-09-17 | Conversion | 862,587 | ||
|
Bicara Therapeutics Inc BCAX
Series C Preferred Stock · derivative
|
2024-09-17 | Conversion | 7,973,325 | ||
|
Bicara Therapeutics Inc BCAX
Series C Preferred Stock · derivative
|
2024-09-17 | Conversion | 7,973,325 | ||
|
AdaptHealth Corp AHCO
Class A Common Stock
|
2024-03-12 | Sell | 114,906 | $10.70 | 1,229,494 |
|
AdaptHealth Corp AHCO
Class A Common Stock
|
2024-03-11 | Sell | 88,040 | $11.13 | 979,885 |
|
AdaptHealth Corp AHCO
Class A Common Stock
|
2024-03-11 | Sell | 94,567 | $10.92 | 1,032,672 |
| showing 20 of 200 most recent transactions | |||||